Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 20, 2026 10:30 ET | Source: ADARx Pharmaceuticals

ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data and Phase 3 Design at the 2026 AAAAI Annual Meeting

ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data and Phase 3 Design at the 2026 AAAAI Annual Meeting
February 18, 2026 10:46 ET | Source: Research and Markets

RNA Interference Therapy Competitive Landscape Research 2026: Comprehensive Insights About 40+ Companies and 90+ Drugs - Collaborations, Acquisitions, and Licensing Deals

Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "RNA Interference Therapy-Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The "RNA Interference Therapy -...
January 30, 2026 06:28 ET | Source: Research and Markets

$23.65 Bn RNA Analysis Market Trends Analysis and Growth Forecast to 2033

Dublin, Jan. 30, 2026 (GLOBE NEWSWIRE) -- The "RNA Analysis Market Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.The global RNA analysis market size was estimated at...
January 29, 2026 09:29 ET | Source: Research and Markets

$33.84 Bn Nucleic Acid Therapeutics Contract Manufacturing Market Size, Share & Trends Analysis and Growth Forecasts to 2033

Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "Nucleic Acid Therapeutics Contract Manufacturing Market Size, Share & Trends Analysis Report by Type (Gene Therapy, RNA-based Therapies), Service,...
January 23, 2026 07:06 ET | Source: Research and Markets

Automated and Closed Cell Therapy Processing Systems Market Report 2026-2031: Analysis by Workflow, Type, Scale and Region

Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "Automated and Closed Cell Therapy Processing Systems Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added...
January 21, 2026 11:18 ET | Source: Research and Markets

Exploring Investment Opportunities in the Expanding RNA Therapy Clinical Trials Market: A USD 4.28 Billion Valuation by 2031

Dublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The "RNA Therapy Clinical Trials Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...
January 21, 2026 04:42 ET | Source: Research and Markets

Middle East Exosomes Market Research Report 2025-2033: Diagnostic and Therapeutic Adoption, R&D Investment, and Liquid Biopsy Demand Drive Growth

Dublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The "Middle East Exosomes Market Size, Share & Trends Analysis Report by Product & Service (Kits & Reagents, Instruments, Services), Workflow...
January 20, 2026 10:08 ET | Source: Research and Markets

Genomics Market Research Report 2025: Innovations are Accelerating the Transition to Faster Diagnostics, Scalable Biomanufacturing, and Precision Therapies

Dublin, Jan. 20, 2026 (GLOBE NEWSWIRE) -- The "Genomics" report has been added to ResearchAndMarkets.com's offering.Genomic innovation is accelerating the transition to faster diagnostics, scalable...
January 16, 2026 04:04 ET | Source: Research and Markets

Strategic Insights into RNA Therapy: Adapting to Regulatory Changes and Supply Chain Shifts for Sustained Growth

Dublin, Jan. 16, 2026 (GLOBE NEWSWIRE) -- The "RNA Therapy Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.The RNA therapy market is expected to grow from...
January 15, 2026 11:08 ET | Source: Research and Markets

Genetic Modification Therapies Set to Surge, Market Valued at $32.1 Billion by 2030

Dublin, Jan. 15, 2026 (GLOBE NEWSWIRE) -- The "Genetic Modification Therapies Clinical Applications: Gene Therapies, Genetically Modified Cell Therapies, RNA Therapies and Gene Editing" has been...